Simulation-Guided Clinical Trials: Is EU Law Ready?
Simulations do not replace human judgment: they inform it, making transparent what would otherwise remain…
Simulation-Guided Clinical Trials: Is EU Law Ready?
Simulations do not replace human judgment: they inform it, making transparent what would otherwise remain a “black box.” EU law does not require them today; but a proportionate embrace, in the right legislative vehicle, with clear methodological standards, and without crushing noncommercial research, could make trials safer, faster, cheaper, and more reliable, without sacrificing rigor….
AI and the Future of Revenue Cycle Management
Upcoming Healthcare Innovation webinar explores how health systems can use AI to improve financial performance, streamline operations, and reduce administrative burden.
Nkarta Autoimmune Disease Cell Therapy’s First Human Data Show Safety, Signs of Efficacy
Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic sclerosis, during the American College of Rheumatology annual in Orlando this week. The biotech is part of a growing group of companies developing therapies that reset the immune system to treat autoimmune disease. The post Nkarta Autoimmune…
Stop Testing AI Against Doctors. Test Doctors With AI.
By MANUEL PINILLA Every few months a new study reports that an AI model has outperformed doctors on a set of diagnostic cases. The latest one I’ve read came out in Science in October: Microsoft’s MAI-DxO, tested on 304 complex cases from the New England Journal of Medicine and run as step-by-step simulations, reached the…
What’s Driving the Consumerization of Healthcare?
Patients increasingly expect convenient, consumer-focused healthcare experiences, panelists said at the recent MedCity INVEST Digital Health Conference. The post What’s Driving the Consumerization of Healthcare? appeared first on MedCity News.
Missing the Point: Isolation Alone Will Not Build AI Safety
Treating AI agents like contract nurses and minimizing their access to critical patient information certainly reduces potential risk. But, it also minimizes key opportunities. The post Missing the Point: Isolation Alone Will Not Build AI Safety appeared first on MedCity News.
Our Reporters Discuss Healthcare Costs — And What Changes the Midterms May Portend
KFF Health News chief Washington correspondent Julie Rovner discussed how Congress can combat the rising cost of healthcare on WAMU’s 1A on Nov. 5, healthcare affordability on MS NOW’s Money, Power, Politics With Stephanie Ruhle on Oct. 30, and the politics of healthcare on Slate’s What Next podcast on Oct. 27. Click here to hear…
Texas Democrats Swept Statewide Races. Now Comes the Hard Part of Solving Healthcare Angst.
Texas Democrats spent three decades trying to regain control of the governor’s mansion and other top state leadership positions. This Election Day, they pulled off a decisive upset, taking statewide offices and the state House, partly due to voter anger over healthcare costs and the difficulty of getting care. Now the state’s newly elected leaders…
Midterm Election Results Could Reshape Health Policy Debate, Experts Say
Election polling showed widespread concern about healthcare costs, putting pressure on lawmakers to address coverage, premiums and access to care
Bispecific J&J Drug Wins Speedy FDA Approval for Treating Head & Neck Cancer
Accelerated FDA approval of Johnson & Johnson’s Rybrevant Faspro covers advanced cases of head and neck cancer. The bispecific antibody was initially approved for treating certain lung cancers. The post Bispecific J&J Drug Wins Speedy FDA Approval for Treating Head & Neck Cancer appeared first on MedCity News.
